Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CAO Ryan M. Bartolucci sold 13,770 shares of the stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares of the company's stock, valued at approximately $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Shares of TEM traded up $0.20 during midday trading on Friday, reaching $57.39. The stock had a trading volume of 17,835,202 shares, compared to its average volume of 10,322,798. The firm has a 50 day simple moving average of $44.18 and a 200-day simple moving average of $48.18. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Tempus AI by 166.0% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after buying an additional 2,021,394 shares during the last quarter. ARK Investment Management LLC boosted its position in Tempus AI by 355.0% during the third quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock worth $134,604,000 after purchasing an additional 1,855,459 shares during the period. NEA Management Company LLC increased its holdings in shares of Tempus AI by 17.8% in the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock valued at $304,846,000 after purchasing an additional 813,169 shares during the last quarter. Millennium Management LLC bought a new position in shares of Tempus AI in the second quarter valued at about $8,067,000. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of Tempus AI during the 2nd quarter worth about $5,250,000. Institutional investors own 24.22% of the company's stock.
Several equities research analysts have recently issued reports on TEM shares. Bank of America increased their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a research report on Friday, December 13th. Stifel Nicolaus downgraded Tempus AI from a "buy" rating to a "hold" rating and lifted their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Wolfe Research assumed coverage on Tempus AI in a research report on Friday, December 13th. They set an "outperform" rating and a $60.00 price objective for the company. Piper Sandler reissued a "neutral" rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Finally, Guggenheim started coverage on Tempus AI in a research report on Monday, December 9th. They set a "buy" rating and a $74.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $56.36.
Get Our Latest Research Report on TEM
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.